Latest filing published 16 Oct 2026 for Moleculin Biotech, Inc.. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jonathan P. Foster, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Moleculin Biotech, Inc. and Empery Digital Inc. Between 16 June 2022 and 15 October 2026, the trades on record add up to 18 filings.
On the market, this insider has only ever bought: 2 purchases, €18k in total. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants and 12 option exercises. In 2026 alone, the filings show 1 purchase and no sales.
Most recently, on 16 October 2026, the filings show a share grant worth €10k in Moleculin Biotech, Inc. The last insider purchase was made public on 5 August 2026, 74 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations